Acquired Hemophilia Overview

Save information for later
Sign Up

Learn About Acquired Hemophilia

What is the definition of Acquired Hemophilia?
Acquired hemophilia is a bleeding disorder that interferes with the body's blood clotting process. Signs and symptoms include prolonged bleeding, frequent nosebleeds, bruising throughout the body, solid swellings of congealed blood (hematomas), hematuria, and gastrointestinal or urologic bleeding. Acquired hemophilia occurs when the body's immune system attacks and disables a certain protein that helps the blood clot. About half of the cases are associated with other conditions, such as pregnancy, autoimmune disease, cancer, skin diseases, or allergic reactions to medications.
What are the alternative names for Acquired Hemophilia?
  • Acquired hemophilia
  • Acquired haemophilia
Who are the top Acquired Hemophilia Local Doctors?
Keiji Nogami
Elite in Acquired Hemophilia
Keiji Nogami
Elite in Acquired Hemophilia
Keiji Nogami
Kashihara-shi, JP 

Keiji Nogami practices in Kashihara-shi, Japan. Mr. Nogami is rated as an Elite expert by MediFind in the treatment of Acquired Hemophilia. His top areas of expertise are Hemophilia A, Blood Clots, Acquired Hemophilia, Synovectomy, and Adenoidectomy.

Elite in Acquired Hemophilia
Andreas Tiede
Elite in Acquired Hemophilia
Andreas Tiede
Carl Neuberg Str. 1, 
Hannover, NI, DE 

Andreas Tiede practices in Hannover, Germany. Mr. Tiede is rated as an Elite expert by MediFind in the treatment of Acquired Hemophilia. His top areas of expertise are Acquired Hemophilia, Blood Clots, Hemophilia A, and Von Willebrand Disease (VWD).

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Acquired Hemophilia
Paul N. Knobl
Elite in Acquired Hemophilia
Paul N. Knobl
Vienna, AT 

Paul Knobl practices in Vienna, Austria. Mr. Knobl is rated as an Elite expert by MediFind in the treatment of Acquired Hemophilia. His top areas of expertise are Acquired Hemophilia, Purpura, Thrombocytopenia, Blood Clots, and Splenectomy.

View All Doctors
What are the latest Acquired Hemophilia Clinical Trials?
A Multicenter, Single-arm Exploratory Study of CD38 (Daratumumab) Monoclonal Antibody (Daratumumab) Combined Corticosteroid in the Treatment of Acquired Hemophilia A (AHA)
A Multicenter, Single-arm Exploratory Study of CD38 (Daratumumab) Monoclonal Antibody (Daratumumab) Combined Corticosteroid in the Treatment of Acquired Hemophilia A (AHA)
Enrollment Status: Recruiting
Publish Date: August 05, 2025
Intervention Type: Drug
Study Phase: Phase 4

Summary: To evaluate the time of response, sustained remission rate and relapse rate of CD38 monoclonal antibody (Daratumumab) combined corticosteroid in the treatment of AHA. To evaluate the safety of CD38 monoclonal antibody in the treatment of AHA.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Emicizumab in Patients With Acquired Hemophilia A: Multicenter, Single-arm, Open-label Clinical Trial
Emicizumab in Patients With Acquired Hemophilia A: Multicenter, Single-arm, Open-label Clinical Trial
Enrollment Status: Recruiting
Publish Date: June 03, 2025
Intervention Type: Drug
Study Phase: Phase 2

Summary: This is a phase II multicenter open-label, single-arm prospective study to evaluate the efficacy of prophylactic emicizumab administered on a scheduled basis to prevent bleeds in patients with acquired hemophilia A (AHA).

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center